Overview Dosage Guide Side Effects Protocol Results Weight LossClinical TrialsInjection Guide GLP-3 How to Get Cost FDA Approval Availability Telehealth Liver Fat Muscle Loss Where to Buy

Tirzepatide Clinical Trials: Results & How to Enroll

Complete guide to Tirzepatide clinical trial history, published results, and current research status.

Clinical Trial History

Phase 3 (SURMOUNT-1)

Weight reduction in adults with obesity

Participants on 15mg tirzepatide lost an average of 22.5% of body weight over 72 weeks, compared to 2.4% for placebo.

Source: NEJM 2022; SURMOUNT-1

Phase 3 (SURPASS-2)

HbA1c reduction vs semaglutide in T2D

Tirzepatide 15mg reduced HbA1c by 2.46% vs 2.33% for semaglutide 1mg, and produced greater weight loss (12.4kg vs 6.2kg).

Source: NEJM 2021; SURPASS-2

Frequently Asked Questions

What clinical trials have studied Tirzepatide?

Tirzepatide has been studied in multiple clinical trials. The key findings are documented in the clinical research section of this guide. Refer to ClinicalTrials.gov for complete trial records and enrollment information.

Is Tirzepatide still in clinical trials?

FDA approved for T2D (Mounjaro, 2022) and obesity (Zepbound, 2023). For current trial status, search ClinicalTrials.gov using the drug name "Tirzepatide".

References & Sources

Exploring Retatrutide Access?

See how patients are accessing retatrutide through physician-supervised telehealth and compounding pharmacies.

Not FDA approved. Access requires physician oversight.

Affiliate links — we may earn a commission at no cost to you.

Compare Providers →

Medical Disclaimer: Clinical trial information is based on publicly available data from ClinicalTrials.gov and published research. This content does not constitute medical advice.